Marcus, Ronald N <br/><br/>
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.  [electronic resource] 

 -  Journal of clinical psychopharmacology  Apr 2008 
 - 156-65 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0271-0749 
<br/><br/><label>Standard No.: </label>10.1097/JCP.0b013e31816774f9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Akathisia, Drug-Induced--etiology<br/>Antidepressive Agents--adverse effects<br/>Aripiprazole<br/>Citalopram--adverse effects<br/>Cyclohexanols--adverse effects<br/>Depressive Disorder, Major--drug therapy<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Fatigue--chemically induced<br/>Female<br/>Fluoxetine--adverse effects<br/>Humans<br/>Male<br/>Middle Aged<br/>Paroxetine--adverse effects<br/>Piperazines--adverse effects<br/>Prospective Studies<br/>Psychiatric Status Rating Scales--statistics & numerical data<br/>Quinolones--adverse effects<br/>Sertraline--adverse effects<br/>Single-Blind Method<br/>Time Factors<br/>Treatment Outcome<br/>Venlafaxine Hydrochloride<br/>Weight Gain--drug effects<br/>Withholding Treatment--statistics & numerical data